Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2/3
    1
    25%
    Phase 4
    3
    75%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    3

    Late Stage

    Phase Distribution4 total trials
    Phase 2/3Combined phases
    1(25.0%)
    Phase 4Post-market surveillance
    3(75.0%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    66.7%

    2 of 3 finished

    Non-Completion Rate

    33.3%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(2)
    Terminated(1)
    Other(1)

    Detailed Status

    Completed2
    unknown1
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 2/31 (25.0%)
    Phase 43 (75.0%)

    Trials by Status

    unknown125%
    withdrawn125%
    completed250%

    Recent Activity

    0 active trials
    Showing 4 of 4
    unknownphase_4

    An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh

    NCT04998344
    completedphase_4

    Immunogenicity and Safety of Sabin-IPV Replacement Vaccination

    NCT04051736
    withdrawnphase_2_3

    Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

    NCT01810731
    completedphase_4

    Inactivated Influenza Vaccine Effectiveness in Tropical Africa

    NCT00893906

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT04998344Phase 4

    An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh

    Unknown
    NCT04051736Phase 4

    Immunogenicity and Safety of Sabin-IPV Replacement Vaccination

    Completed
    NCT01810731Phase 2/3

    Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

    Withdrawn
    NCT00893906Phase 4

    Inactivated Influenza Vaccine Effectiveness in Tropical Africa

    Completed

    All 4 trials loaded

    Drug Details

    Intervention Type
    Biological
    Total Trials
    4